Anastasios Zervas

1.5k total citations
57 papers, 1.2k citations indexed

About

Anastasios Zervas is a scholar working on Surgery, Urology and Molecular Biology. According to data from OpenAlex, Anastasios Zervas has authored 57 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Surgery, 15 papers in Urology and 13 papers in Molecular Biology. Recurrent topics in Anastasios Zervas's work include Bladder and Urothelial Cancer Treatments (16 papers), Urinary and Genital Oncology Studies (12 papers) and Urological Disorders and Treatments (8 papers). Anastasios Zervas is often cited by papers focused on Bladder and Urothelial Cancer Treatments (16 papers), Urinary and Genital Oncology Studies (12 papers) and Urological Disorders and Treatments (8 papers). Anastasios Zervas collaborates with scholars based in Greece, United States and Germany. Anastasios Zervas's co-authors include C Dimopoulos, Dionisios Mitropoulos, Meletios Α. Dimopoulos, Lydia Nakopoulou, Constantinos Constantinides, A. Giannopoulos, Αναστασία Τζώνου, Hariklia Gakiopoulou, L. Nakopoulou and C. Deliveliotis and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and Annals of Oncology.

In The Last Decade

Anastasios Zervas

56 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anastasios Zervas Greece 19 584 306 275 261 201 57 1.2k
Shunta Hori Japan 18 674 1.2× 448 1.5× 321 1.2× 474 1.8× 189 0.9× 169 1.5k
Sílvio Tucci Brazil 20 487 0.8× 204 0.7× 215 0.8× 73 0.3× 228 1.1× 122 1.1k
Jehoram T. Anim Kuwait 17 308 0.5× 175 0.6× 159 0.6× 126 0.5× 96 0.5× 44 762
Yosuke Morizawa Japan 16 571 1.0× 382 1.2× 295 1.1× 416 1.6× 192 1.0× 143 1.3k
Yasuhide Kitagawa Japan 17 177 0.3× 326 1.1× 437 1.6× 249 1.0× 114 0.6× 61 1.1k
Heinz Pflüger Austria 22 281 0.5× 258 0.8× 143 0.5× 118 0.5× 483 2.4× 62 1.2k
Patrick F. Keane United Kingdom 17 310 0.5× 351 1.1× 151 0.5× 128 0.5× 238 1.2× 57 886
Marco Racioppi Italy 22 915 1.6× 539 1.8× 286 1.0× 214 0.8× 584 2.9× 134 1.7k
Kikuo Okamura Japan 15 575 1.0× 160 0.5× 192 0.7× 111 0.4× 528 2.6× 76 1.2k
Tao Xu China 18 230 0.4× 179 0.6× 357 1.3× 250 1.0× 33 0.2× 104 1.0k

Countries citing papers authored by Anastasios Zervas

Since Specialization
Citations

This map shows the geographic impact of Anastasios Zervas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anastasios Zervas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anastasios Zervas more than expected).

Fields of papers citing papers by Anastasios Zervas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anastasios Zervas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anastasios Zervas. The network helps show where Anastasios Zervas may publish in the future.

Co-authorship network of co-authors of Anastasios Zervas

This figure shows the co-authorship network connecting the top 25 collaborators of Anastasios Zervas. A scholar is included among the top collaborators of Anastasios Zervas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anastasios Zervas. Anastasios Zervas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stravodimos, Konstantinos, Andreas C. Lazaris, Georgios Agrogiannis, et al.. (2009). Hydronephrosis Promotes Expression of Hypoxia-Inducible Factor 1α. Urologia Internationalis. 82(1). 38–42. 13 indexed citations
2.
Mitropoulos, Dionisios, Andreas Petrolekas, Ιoannis Anastasiou, et al.. (2008). Differences in presentation characteristics of renal cell carcinoma in the last 25 years: a single center experience. Journal of Cancer Research and Clinical Oncology. 134(12). 1297–1301. 4 indexed citations
3.
Mylona, Eugenia, et al.. (2008). Peroxisome proliferator-activated receptor gamma expression in urothelial carcinomas of the bladder: Association with differentiation, proliferation and clinical outcome. European Journal of Surgical Oncology. 35(2). 197–201. 19 indexed citations
4.
Constantinides, Constantinos, Stavros Ι. Tyritzis, Andreas Skolarikos, et al.. (2008). Short‐ and long‐term complications of open radical prostatectomy according to the Clavien classification system. British Journal of Urology. 103(3). 336–340. 53 indexed citations
5.
Constantinides, Constantinos, et al.. (2007). Multiple Metastases of Prostatic Adenocarcinoma to the Urethra after Radical Prostatectomy. Urologia Internationalis. 79(1). 92–93. 1 indexed citations
6.
Adamakis, Ioannis, et al.. (2007). Enucleoresection for the Elective Treatment of Small Renal Cell Carcinoma: Can It Be the Treatment of Choice?. Oncology Research and Treatment. 30(3). 97–102. 5 indexed citations
7.
Tyritzis, Stavros Ι., A. Kyroudi, Evangelos Liatsikos, et al.. (2007). Comparison of prolonged warm and cold ischemia on the solitary kidney during partial nephrectomy in a rabbit model. World Journal of Urology. 25(6). 635–640. 13 indexed citations
8.
Constantinides, Constantinos, Stavros Ι. Tyritzis, A. Kyroudi, et al.. (2007). Vascular Endothelial Growth Factor Protein Expression in a Renal Ablation Rabbit Model under Prolonged Warm and Cold Ischemia. American Journal of Nephrology. 28(3). 438–445. 7 indexed citations
9.
Mitropoulos, Dimitris, et al.. (2006). Delayed surgical treatment of benign prostatic hyperplasia: a subjective estimation of change in the operative risk profile. The Journal of Men s Health and Gender. 3(3). 271–278.
10.
Mitropoulos, Dionisios, George Deliconstantinos, Ioannis Adamakis, et al.. (2004). Changes in End Products of Nitric Oxide in Urine and Induction of Nitric Oxide Synthase Expression in Urinary Bladder During Intravesical Instillations of IFN-α2b. Journal of Interferon & Cytokine Research. 24(10). 621–626. 1 indexed citations
11.
Mitropoulos, Dionisios, et al.. (2002). Symptomatic Benign Prostate Hyperplasia: Impact on Partners’ Quality of Life. European Urology. 41(3). 240–245. 54 indexed citations
12.
Giannopoulou, Ioanna, Lydia Nakopoulou, Anastasios Zervas, et al.. (2002). Immunohistochemical study of pro-apoptotic factors Bax, Fas and CPP32 in urinary bladder cancer: prognostic implications. Urological Research. 30(5). 342–345. 37 indexed citations
13.
Nakopoulou, Lydia, Hariklia Gakiopoulou, Anastasios Zervas, et al.. (2001). MMP-3 mRNA and MMP-3 and MMP-1 Proteins in Bladder Cancer: A Comparison With Clinicopathologic Features and Survival. Applied immunohistochemistry & molecular morphology. 9(2). 130–137. 20 indexed citations
14.
Zervas, Anastasios, et al.. (2000). Extravesical Foreign Body Presenting as a Bladder Tumor. Urologia Internationalis. 65(4). 224–225. 3 indexed citations
15.
Dimopoulos, Meletios Α., Vassilis Georgoulias, Christos Papadimitriou, et al.. (1999). Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: A multicenter phase II study of the Hellenic Cooperative Oncology Group. Annals of Oncology. 10(11). 1385–1388. 52 indexed citations
16.
Zervas, Anastasios, John Polak, & George Kanellaidis. (1998). SUBJECTIVE HAZARD ASSESSMENT OF GEOMETRIC DESIGN ELEMENTS IN RELATION TO ACCIDENT CAUSATION. IATSS Research. 22(2). 86–93. 4 indexed citations
17.
Nakopoulou, Lydia, et al.. (1998). The prevalence of bcl-2, p53, and ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates. Human Pathology. 29(2). 146–154. 107 indexed citations
18.
Dimopoulos, Meletios Α., Christina Bamia, C. Deliveliotis, et al.. (1997). Oral estramustine and oral etoposide for hormone-refractory prostate cancer. Urology. 50(5). 754–758. 62 indexed citations
19.
Τζώνου, Αναστασία, et al.. (1996). Immunohistochemical evaluation of nm23‐H1 gene product in transitional cell carcinoma of the bladder. Histopathology. 28(5). 429–435. 8 indexed citations
20.
Nakopoulou, L., Anastasios Zervas, C. Constantinides, et al.. (1995). Epithelial Differentiation Antigens and Epidermal Growth Factor Receptors in Transitional Cell Bladder Carcinoma: Correlation with Prognosis. Urologia Internationalis. 54(4). 191–197. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shunta Hori Breakdown of academic impact, for papers by Sílvio Tucci Breakdown of academic impact, for papers by Jehoram T. Anim Breakdown of academic impact, for papers by Yosuke Morizawa Breakdown of academic impact, for papers by Yasuhide Kitagawa Breakdown of academic impact, for papers by Heinz Pflüger Breakdown of academic impact, for papers by Patrick F. Keane Breakdown of academic impact, for papers by Marco Racioppi Breakdown of academic impact, for papers by Kikuo Okamura Breakdown of academic impact, for papers by Tao Xu
Rankless by CCL
2026